INTRODUCTION {#s1}
============

Epithelial components of the vertebrate alimentary tract develop from the endoderm-derived gut tube, which becomes specified into subdivisions along the anteroposterior axis. Early-stage subdivisions of endoderm-derived gut tubes depend on the action of various exogenous signaling molecules ([@BIO048728C9]; [@BIO048728C18]; [@BIO048728C25]), and specification to subdivision results in the expression of subdivision-specific transcription factors (TFs). The epithelial tube of the anterior foregut (AFG) and stomach expresses SOX2 after embryonic day (E) 9 ([@BIO048728C15]), whereas the hindgut, which develops into duodenum and more posterior intestinal regions, expresses CDX2 ([@BIO048728C5]). The anterior portion of AFG epithelial tubes is then split into dorsally positioned SOX2-expressing esophagus tissues and ventrally positioned tracheal tissues that express NKX2.1 and SOX2. Bronchi, bronchioles and alveoli that further develop at the distal end of the trachea also express NKX2.1 ([@BIO048728C18]; [@BIO048728C25]).

TFs that are expressed in endoderm-derived epithelial tubes play determining roles during gut subdivision. For instance, endoderm-specific inactivation of *Cdx2* promoted SOX2 expression in hindgut tubes, which assumed forestomach epithelial cell characters ([@BIO048728C5]). Loss of *Nkx2.1* in embryos resulted in the development of esophagus and tracheal structures that remained joined, and caused defects in lung branching morphogenesis ([@BIO048728C12]).

Contributions of SOX2 to esophageal specification of AFG epithelia have been demonstrated using combinations of hypomorphic *Sox2* alleles, leading to degrees of tracheoesophageal fistula ([@BIO048728C15]), similar to various aspects of human congenital tracheoesophageal fistula cases ([@BIO048728C23]; [@BIO048728C25]). Hence, SOX2 function is essential for the separation of trachea and esophagus in the AFG and required for the establishment of esophageal epithelial characteristics. However, complete tissue-specific *Sox2* inactivation is required to precisely evaluate the roles of SOX2 in these processes. We achieved endoderm-specific inactivation of *Sox2* using a floxed *Sox2* allele and a *FoxA2*-*nEGFP*-*CreERT2* knock-in allele, in which coding sequences were joined via 2A peptide sequences ([@BIO048728C7]). Under these conditions, tamoxifen administration resulted in the development of a single SOX2-deficient AFG tube connecting the pharynx and the stomach, in the middle of which a pair of bronchi branched out.

Mesenchymal influences on epithelial subdivisions of the AFG have been well documented ([@BIO048728C18]; [@BIO048728C25]). In this study, we characterized both epithelial and mesenchymal components of the AFG after formation in the absence of SOX2 in the epithelium. Not only the SOX2-deficient AFG epithelia but also the surrounding mesenchymal tissues developed into those of respiratory organs, with clear anteroposterior polarity similar to those of the trachea and bronchi. Thus, once established, the regional identity of the epithelial component of the AFG determined the characters of the surrounding mesenchymal tissues.

RESULTS AND DISCUSSION {#s2}
======================

Organization of AFG tube development in the absence of endodermal SOX2 expression {#s2a}
---------------------------------------------------------------------------------

To inactivate *Sox2* expression in the entire gut tube, we introduced *Foxa2^nEGFP−CreERT2^* ([@BIO048728C7]) into floxed *Sox2* homozygous mice ([Fig. S1A--C](Fig. S1A–C)). Tamoxifen was administered to pregnant females on E7 and E8, shortly before the expression of *FoxA2* in the foregut at E8.5 ([@BIO048728C7]), and embryos were collected on E11 to E13. In the floor plate-proximal ventral spinal cord, where the expression of *Sox2* and *FoxA2* normally overlaps, SOX2 expression was abolished ([Fig. S1D](Fig. S1D)), confirming that *Sox2* was efficiently inactivated by CreERT2.

We investigated AFG development in the absence of SOX2 expression ([Fig. 1](#BIO048728F1){ref-type="fig"}). AFG epithelial tubes were visualized using *FoxA2*-driven nuclear EGFP fluorescence ([Fig. 1](#BIO048728F1){ref-type="fig"}A; [Fig. S2](Fig. S2)). In normal E11 to E13.5 embryos, the esophagus joins the pharynx and stomach, and the trachea with a pair of bronchi with lung tissues was already separated ([Fig. 1](#BIO048728F1){ref-type="fig"}A). In the absence of SOX2 expression, however, a single AFG tube connecting the pharynx and stomach was formed, and a pair of bronchi with lung tissues developed in the middle of these tubes ([Fig. 1](#BIO048728F1){ref-type="fig"}A). In a significant fraction (12/17) of SOX2-deficient AFG, bronchiole-like tubular tissues developed from the posterior half ([Fig. 1](#BIO048728F1){ref-type="fig"}A; [Fig. S2](Fig. S2), arrows). The same AFG tube phenotype was observed using knock-in of CreERT2 into the ROSA26 locus ([@BIO048728C3]), although in this case, brain tissue development was also affected (data not shown). Loss of SOX2 expression in endoderm-derived epithelia expressing EGFP was confirmed by immunostaining of cross sections ([Fig. 1](#BIO048728F1){ref-type="fig"}B,C). Fig. 1.**Absence of the esophagus and expression of NKX2.1 in all epithelial tubes of SOX2-deficient (ΔSOX2) AFG.** (A) AFG tube organization was visualized in the dorsal view by *FoxA2*-driven EGFP in WT AFG and ΔSOX2 AFG on E13.5. WT AFG had separate esophageal (Es) and tracheal (Tr)/bronchial (Br) tubes, whereas ΔSOX2 AFG bronchi developed in the middle of the single tube connecting the pharynx and stomach. Frequently (12/17), bronchiole-like tissues developed from the posterior half of ΔSOX2 AFG, as indicated by arrows. Stomachs of ΔSOX2 were always smaller. Scale bars: 500 µm. For more specimens from earlier developmental stages, see [Fig. S2](Fig. S2). (B,C) Cross sections of AFG tubes of WT (B) and ΔSOX2 (C) E13 embryos at approximate axial levels as shown in A. The sections were immunostained for EGFP (green), SOX2 (green) and NKX2.1 (red), and the fluorescence images were superimposed on 4′,6-diamidino-2-phenylindole (DAPI) fluorescence to show the cell distribution. SOX2 and NKX2.1 data were from the same embryos, whereas EGFP data were from stage-matched different embryos. Sections of tubular tissues are encircled by broken lines, and those expressing relevant antigens are indicated by the following tissue abbreviations: AFG with an arrowhead indicates the ΔSOX2 AFG epithelium, while Es, Tr, and Br indicate esophagus, trachea, and bronchi, respectively. In ΔSOX2 AFG, the entire epithelial tube lacked SOX2 and expressed NKX2.1. See also [Fig. S3](Fig. S3). Scale bars: 100 µm.

In normal embryos, proximal branches of the epithelial tubes, i.e. trachea and bronchi, also express SOX2 ([Fig. 1](#BIO048728F1){ref-type="fig"}B; [Fig. S3A](Fig. S3A)) ([@BIO048728C6]; [@BIO048728C16]; [@BIO048728C23]). Airway epithelia that developed in the absence of SOX2 showed tissue growth and branching patterns identical to normal embryos ([Fig. 1](#BIO048728F1){ref-type="fig"}A; [Fig. S2](Fig. S2)), indicating that SOX2 function is dispensable for lung morphogenesis at least up to the E13 stage. It has been shown that SOX2 is involved in cell type specification at later stages of lung development ([@BIO048728C16]).

SOX2-deficient stomach tissues were smaller than normal (*n*\>10) ([Fig. 1](#BIO048728F1){ref-type="fig"}A; [Fig. S2](Fig. S2)), but did not express NKX2.1 (*n*=3) ([Fig. S3B](Fig. S3B)). CDX2 is normally expressed in hindgut epithelia to form SOX2--CDX2 boundaries at the pylorus. In the absence of CDX2 expression, hindgut epithelia expressed SOX2 and assumed a forestomach character ([@BIO048728C5]). In contrast, the absence of SOX2 expression did not activate CDX2 expression in the stomach epithelia (*n*=3) ([Fig. S3C](Fig. S3C)).

SOX2-deficient single AFG epithelial tubes have tracheal and bronchial characters {#s2b}
---------------------------------------------------------------------------------

SOX2-deficient AFG epithelial tubes connecting the pharynx and stomach expressed NKX2.1 at all axial levels during the stages E11 to E13.5 (*n*=4) ([Fig. 1](#BIO048728F1){ref-type="fig"}C; [Fig. S3A,B](Fig. S3A,B)), indicating tracheal/bronchial characteristics. Accordingly, on E13.5, SOX2-deficient AFG tubes ([Fig. 2](#BIO048728F2){ref-type="fig"}Bd,e,e′,f) were wider than normal esophagi ([Fig. 2](#BIO048728F2){ref-type="fig"}Ba,b,b′,c), again showing tracheal and bronchial characteristics. Consistently, SOX2-deficient AFG tubes comprised of columnar (Co) epithelia similar to wild-type (WT) bronchi, as indicated by the distribution of Hematoxylin-stained nuclei ([Fig. 2](#BIO048728F2){ref-type="fig"}Bd,e,e′,f) and the organization of cell boundaries indicated by E-cadherin immunostaining ([Fig. 2](#BIO048728F2){ref-type="fig"}Bd), whereas WT esophagi comprised pseudo-stratified (PS) epithelial tissues at this stage ([Fig. 2](#BIO048728F2){ref-type="fig"}Ba,b,b′,c), a transition state between the earlier columnar and later stratified epithelia of the esophagus ([@BIO048728C14]). Fig. 2.**Epithelial tubes in ΔSOX2 AFG exhibit tracheal/bronchial characters.** Histological sections of E13 epithelial tubes made at the axial levels shown in [Fig. 1](#BIO048728F1){ref-type="fig"}A, as schematized in A. (B) H&E staining of embryo cross sections. E-cadherin (E-cad)-stained cryosections at the axial levels (a) and (d) of embryos at similar developmental stages are also shown. ΔSOX2 AFG tubes were wider than WT esophageal tubes, and similar to WT trachea. Whereas WT tracheal (Tr)/bronchial (Br) tubes and ΔSOX2 AFG tubes comprised columnar (Co) epithelium, WT esophageal tubes (Es) comprised pseudo-stratified epithelium (PS), as judged by nuclear arrangements and organization of cell boundaries visualized by E-cadherin immunostaining in panels a and d. (C) Immunostaining of cryosections for SOX9 at approximate axial levels shown in [Fig. 1](#BIO048728F1){ref-type="fig"}A. SOX9 expression level was high in posterior ΔSOX2 AFG tubes (e′), similar to the distal bronchi in both WT and ΔSOX2 embryos. The open arrowhead indicates the region of transition from low to high SOX9 expression. Scale bars: 100 µm.

On E13, proximal and distal epithelial portions of respiratory organ rudiments differ in SOX9 expression levels ([@BIO048728C23]): low in the trachea and proximal bronchi ([Fig. 2](#BIO048728F2){ref-type="fig"}Ca,b) and high in the distal bronchi ([Fig. 2](#BIO048728F2){ref-type="fig"}Cb′). In contrast, in WT esophagi, SOX9 expression did not differ significantly between the anterior and posterior halves (*n*=5), although the expression levels were variable between embryos and sometimes only barely detectable. In SOX2-deficient AFG tubes, epithelial SOX9 expression was low in the anterior part ([Fig. 2](#BIO048728F2){ref-type="fig"}Cd,e) but higher in a posterior part (*n*=4) ([Fig. 2](#BIO048728F2){ref-type="fig"}Ce′), indicating that the anterior and posterior sides of the AFG developed as trachea and bronchi, respectively. Given that ordinary pairs of bronchi branched out from the midpoint of SOX2-deficient AFG tubes, the AFG region between the midpoint and the stomach developed as a third bronchus. Consistently, additional bronchiole-like tissues frequently developed from the posterior half of SOX2-deficient AFG (*n*=12/17) ([Fig. 1](#BIO048728F1){ref-type="fig"}A; [Fig. S2](Fig. S2), arrows).

Surrounding mesenchymal tissues developed concordant with the epithelial tissue identity {#s2c}
----------------------------------------------------------------------------------------

We investigated whether mesenchymal tissues surrounding SOX2-deficient AFG tubes developed concordantly with the tracheal and bronchial characteristics of the epithelia.

In normal embryos on E13, the epithelial tubes of the esophagus were surrounded by smooth muscle cells expressing smooth muscle α-actin (α-SM) at positions distal from the tube ([Fig. 3](#BIO048728F3){ref-type="fig"}A, arrowheads) ([@BIO048728C11]) and were not associated with SOX9-expressing cells ([Fig. 3](#BIO048728F3){ref-type="fig"}A). In contrast, the epithelial tubes of the trachea and bronchi were tightly wrapped in two patches of mesenchymal cells, representing smooth muscle cells and SOX9-expressing chondrocyte progenitors ([Fig. 3](#BIO048728F3){ref-type="fig"}A). These smooth muscle patches were positioned at the dorsal face of the trachea and median faces of the bronchi and were broader surrounding the bronchi ([Fig. 3](#BIO048728F3){ref-type="fig"}A, broken double arrows). The anterior halves of SOX2-deficient AFG tubes were also tightly wrapped in a narrower patch of smooth muscle cells and a broader patch of SOX9-expressing cells, exactly as observed in normal trachea (*n*=3) ([Fig. 3](#BIO048728F3){ref-type="fig"}Aa,d). These data indicate that trachea-like development of the anterior epithelial tube elicits mesenchymal developments with characteristics of respiratory organs. Fig. 3.**Mesenchymal characters are concordant with those of epithelial tubes in the AFG.** Histological sections of E13 epithelial tubes are shown at the axial levels indicated in [Fig. 1](#BIO048728F1){ref-type="fig"}A. (A) Sections shown in [Fig. 2](#BIO048728F2){ref-type="fig"}B were doubly stained for SOX9 (green) and α-SM (magenta). Mesenchymal tissues surrounding WT and ΔSOX2 trachea/bronchi comprise nearly complementary patches of SOX9-expressing cells and α-SM-expressing cells (broken double arrows). ΔSOX2 AFG tubes were also wrapped in SOX9- and α-SM-expressing mesenchymal tissues, albeit without their separation into patches (open arrowheads). In contrast, WT esophageal tissues lacked these cell types and only had distal α-SM-expressing cells (arrowheads). (B--D) Analogous sections of WT and ΔSOX2 AFG hybridized with mesenchyme-specific gene probes for *Wnt4* (esophagus specific), *Tbx4* (trachea/bronchus specific), and *Hoxb6* (distal bronchus specific). Mesenchymal cells expressing these genes are indicated by open arrowheads. In ΔSOX2 AFG, *Wnt4* expression was completely absent (B), epithelial tubes were all surrounded by *Tbx4*-expressing mesenchyme (C), and the posterior part of the tube was surrounded by *Hoxb6-*expressing mesenchyme, similar to the distal bronchi (D). Asterisk, an AFG-derived bronchiole-like tube. Scale bars: 100 µm.

In the posterior parts of SOX2-deficient AFG, the epithelial tubes were surrounded by smooth muscle cells and SOX9-expressing cells, resembling bronchi. Yet, smooth muscle cells and SOX9-expressing cells did not segregate (*n*=3) ([Fig. 3](#BIO048728F3){ref-type="fig"}Ae,e′, open arrowheads). Presumably, azimuthal specification of the mesenchyme failed to occur in SOX2-deficient AFG.

To investigate the molecular markers of mesenchymal cells that distinguish esophagus and respiratory organs, we performed *in situ* hybridization using esophagus mesenchyme-specific *Wnt4* ([Fig. 3](#BIO048728F3){ref-type="fig"}Ba,b′) (GSE118641, Gene Expression Omnibus), respiratory organ-specific *Tbx4* ([Fig. 3](#BIO048728F3){ref-type="fig"}Ca,b′) ([@BIO048728C1]), and *Hoxb6*, which is expressed in the distal portion of the bronchus mesenchyme ([Fig. 3](#BIO048728F3){ref-type="fig"}Dd).

In normal embryos on E11 to 11.5, *Wnt4* was expressed in mesenchymal cells surrounding the esophagus ([Fig. 3](#BIO048728F3){ref-type="fig"}Ba,b′, open arrowheads). In contrast, *Wnt4* expression was lost in mesenchymal tissues surrounding SOX2-deficient AFG epithelial tubes (*n*=3) ([Fig. 3](#BIO048728F3){ref-type="fig"}Bd,e′), confirming the loss of esophageal phenotypes. In contrast, *Tbx4* was expressed exclusively in the mesenchyme of respiratory organs in normal embryos ([Fig. 3](#BIO048728F3){ref-type="fig"}Ca,b′, open arrowheads) ([@BIO048728C1]). Mesenchymal tissues of SOX2-deficient AFG expressed *Tbx4* at all axial levels (*n*=3) ([Fig. 3](#BIO048728F3){ref-type="fig"}Cd,e′, open arrowheads), concordant with the respiratory organ identity of the epithelial tubes.

In normal embryos, *Hoxb6* was expressed in mesenchymal tissues surrounding the distal part of the bronchus (and more strongly in alveoli) ([Fig. 3](#BIO048728F3){ref-type="fig"}Dc, open arrowheads), but no expression was observed along the trachea ([Fig. 3](#BIO048728F3){ref-type="fig"}Da). Along the SOX2-deficient AFG, only the mesenchyme surrounding the posterior AFG tubes and posterior AFG-derived bronchiole-like tubes ([Fig. 3](#BIO048728F3){ref-type="fig"}Df, asterisk) expressed *Hoxb6* (*n*=4) ([Fig. 3](#BIO048728F3){ref-type="fig"}Df, open arrowheads), as observed in the distal bronchi ([Fig. 3](#BIO048728F3){ref-type="fig"}Dc,f, open arrowheads). These observations confirmed the bronchial identity of the posterior half of SOX2-deficient AFG, complete with proximodistal polarity in both epithelial and mesenchymal components ([Figs 2](#BIO048728F2){ref-type="fig"}B and [3](#BIO048728F3){ref-type="fig"}D).

Overall impact of the absence of SOX2 during esophageal and tracheal/bronchial development {#s2d}
------------------------------------------------------------------------------------------

We investigated the consequences of abolishing SOX2 expression in the anterior endoderm. Under this condition, single AFG epithelial tubes connecting the pharynx and stomach developed, comprising columnar epithelial cells and expressing NKX2.1, indicating a gain of tracheal/bronchial characteristics and loss of esophageal characteristics ([Figs 1](#BIO048728F1){ref-type="fig"} and [4](#BIO048728F4){ref-type="fig"}). [@BIO048728C20] similarly ablated *Sox2* in the endoderm and reported the development of NKX2.1-expressing AFG epithelia that lacked esophagus-characteristic p63 expression. Fig. 4.**Summary of this study.** (A) The key observations. The loss of SOX2 in the epithelial tissues alters the esophageal characters of the AFG into trachea and bronchi in both epithelial and mesenchymal components. (B) Details of observations. In the diagrams of WT and ΔSOX2 AFG tubes, expression of SOX2, NKX2.1 and SOX9 in the epithelial tissues and expression of α-SM, SOX9, *Wnt4*, *Tbx4* and *Hoxb6* in mesenchymal tissues are indicated.

We also observed anteroposterior differentiation of SOX2-deficient AFG epithelial tubes, similar to proximodistal differentiation of respiratory organ epithelia ([Fig. 2](#BIO048728F2){ref-type="fig"}B). The anterior part of SOX2-deficient AFG epithelial tubes had low SOX9 expression, as in trachea, whereas a posterior part of the tube had high SOX9 expression, as observed in the distal bronchi.

A new important finding of this study is that mesenchymal tissues that surround the epithelial tubes change their characters at all axial levels in concordance with the changes in the epithelial tubes from the esophagus to the respiratory organs ([Figs 3](#BIO048728F3){ref-type="fig"} and [4](#BIO048728F4){ref-type="fig"}). Studies of alimentary tract development have provided a paradigm of epithelial-mesenchymal interactions during organ development ([@BIO048728C18]; [@BIO048728C25]). Earlier studies demonstrated the impact of mesenchyme-derived cues on the development of epithelial tubes. For example, dorsoventral differentiation during the early stages of AFG development, leading to esophagus/trachea splitting, is mediated by BMP signaling from the surrounding mesenchymal cells ([@BIO048728C4]; [@BIO048728C8]). Yet, regulatory influences in SOX2-deficient AFG epithelial tubes were in the opposite direction ([Fig. 4](#BIO048728F4){ref-type="fig"}). All mesenchymal tissues surrounding SOX2-deficient AFG epithelial tubes developed as respiratory organ mesenchyme rather than esophageal mesenchyme. Thus, interactions between epithelial and mesenchymal components during AFG development appear to be bidirectional and dependent on the developmental stage. The underlying mechanisms through which epithelial regional identity determines the characters of the surrounding mesenchyme remain to be elucidated. In a previous study, SOX2-deficient AFG failed to express some Wnt antagonists ([@BIO048728C20]), whereas in other studies, the anteroposterior organization of the gut tube depended on retinoic acid signaling ([@BIO048728C2]; [@BIO048728C22]). Hence, the regulation of these signals by epithelial tissues may contribute to the coordinated development of epithelial and mesenchymal components of the AFG.

MATERIALS AND METHODS {#s3}
=====================

Construction of a mouse line carrying floxed *Sox2* alleles {#s3a}
-----------------------------------------------------------

The mouse genomic sequence from −6307 bp to +9880 bp relative to the 5′ end of the *Sox2* coding sequence, covering the region from N2 to N5 enhancers ([@BIO048728C21]), was used as a targeting vector. The STneoB sequence ([@BIO048728C10]) was flanked by a pair of Flp recombinase target (FRT) sequences and inserted into the vector sequence to select recombinant embryonic stem (ES) cells for G418 resistance. The DT-A cassette ([@BIO048728C24]) was added at the end of the vector sequence to select against non-homologous recombinants. After electroporating the vector in R1 ES cells ([@BIO048728C13]) and selecting recombinants as described by [@BIO048728C17], homologous recombinants were identified by Southern blotting. Homologous recombinants were used to produce mice carrying a floxed *Sox2* allele ([Fig. S1A](Fig. S1A)).

Handling mice and mouse embryos {#s3b}
-------------------------------

Knock-in mice expressing CreERT2 with the specificity of *FoxA2* (*Foxa2^nEGFP−CreERT2^*) ([@BIO048728C7]) or *ROSA26* \[Gt*(ROSA)26Sor^tm1(cre/ERT2)Alj^*\] ([@BIO048728C3]) were crossed with mice carrying the floxed *Sox2* allele and bred for several generations in C57BL/6;DBA mixed background to achieve homozygosity at both loci. Mouse and embryo genotypes were determined using polymerase chain reaction (PCR) with primer pairs that gave PCR products of sizes indicated in [Fig. S1B](Fig. S1B). Five mg of tamoxifen in peanut oil was orally administered to pregnant females on 7.5 and 8.5 days post coitum, and embryos were collected at the indicated stages. Embryos carrying the homozygous floxed *Sox2* allele and the *ROSA26* locus-inserted *CreERT2* recombinase gene \[*Gt(ROSA)26Sortm1(cre/ERT2)Alj*\] ([@BIO048728C3]) showed the *ΔSox2* genotype after the administration of tamoxifen to mothers on E7 and E8. Animal experiments were performed at Kyoto Sangyo University, Nagoya University, Osaka University and Tokushima University in accordance with the animal experimentation regulations of the respective institutions.

Histological analyses {#s3c}
---------------------

Specimens were fixed in 4% paraformaldehyde and processed for histological analyses. Immunofluorescence staining was done using antibodies listed in [Table S1](Table S1). Wholemount *in situ* hybridization of isolated gut tubes was performed using digoxigenin-labeled probes and conditions described by [@BIO048728C19] with Proteinase K treatment at 5 μg/ml, followed by cryosectioning. Paraffin sections of embryos fixed with Bouin\'s fixative were stained with Hematoxylin and Eosin (H&E). Photo images were taken using Axioplan 2 (Zeiss) or an FV3000 laser microscope (Olympus).
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